1. At a Glance – The Sharpest Blade in the Bathroom Cabinet
If FMCG stocks were IPL players, Gillette India would be that elite foreign opener who scores consistently, looks classy, but costs the franchise half the budget. Market cap around ₹27,000 Cr, current price hovering near ₹8,275, and a Stock P/E of ~43.5x — this is not a cheap shave. But then again, Gillette never promised “budget trimming,” only the best a man can get.
Q3 FY26 numbers came in cleaner than a Mach 3 shave:
- Quarterly Sales: ₹790 Cr (+15% YoY)
- Quarterly PAT: ₹172 Cr (+37% YoY)
- Operating Margin: ~31%
- Debt: Practically zero
- ROCE: ~56%
- ROE: ~42%
And just when investors were adjusting their aftershave, the board dropped a ₹180 interim dividend per share (including ₹60 special). Yield chasers smiled, valuation hawks raised an eyebrow.
Three-month return? Meh.
Five-year compounding? Respectable, not heroic.
So the big question: Is this a luxury FMCG cash machine… or a very expensive razor blade? Let’s shave layer by layer.
2. Introduction – A Company That Sells Steel, Smiles, and Habit
Gillette India isn’t really in the business of razors. That’s just the physical product. What it actually sells is habit. Once you enter the Gillette ecosystem, switching feels like shaving with a rusted knife.
The company operates in the grooming and oral care segments — boring on the surface, insanely profitable underneath. Unlike flashy FMCG peers chasing ayurvedic buzzwords or influencer-led shampoos, Gillette plays the long game: brand loyalty, premium pricing, and ruthless SKU discipline.
The India subsidiary benefits massively from its global parent’s R&D muscle. Translation?
- No major R&D spend locally
- No heavy capex
- High asset turns
- Fat margins
But there’s a flip side. Growth is not explosive. This is not a “double revenue in three years” story. It’s a steady compounding, dividend-paying, capital-light FMCG beast.
So before you get excited — ask yourself:
👉 Do you want thrill…
